S&P 500   3,011.98 (+0.17%)
DOW   26,830.10 (+0.01%)
QQQ   193.95 (+0.29%)
AAPL   241.03 (+0.22%)
FB   190.07 (+0.16%)
AMZN   1,776.84 (-0.49%)
CGC   20.35 (+0.00%)
NVDA   198.29 (+1.16%)
BABA   173.65 (+0.07%)
GE   8.63 (-1.82%)
TSLA   254.20 (+0.27%)
AMD   32.04 (+0.03%)
F   8.98 (-0.55%)
ACB   3.64 (-1.36%)
PRI   124.94 (-0.60%)
NFLX   269.83 (-2.96%)
GILD   66.10 (+1.36%)
DIS   132.73 (+1.90%)
S&P 500   3,011.98 (+0.17%)
DOW   26,830.10 (+0.01%)
QQQ   193.95 (+0.29%)
AAPL   241.03 (+0.22%)
FB   190.07 (+0.16%)
AMZN   1,776.84 (-0.49%)
CGC   20.35 (+0.00%)
NVDA   198.29 (+1.16%)
BABA   173.65 (+0.07%)
GE   8.63 (-1.82%)
TSLA   254.20 (+0.27%)
AMD   32.04 (+0.03%)
F   8.98 (-0.55%)
ACB   3.64 (-1.36%)
PRI   124.94 (-0.60%)
NFLX   269.83 (-2.96%)
GILD   66.10 (+1.36%)
DIS   132.73 (+1.90%)
Log in

Compare Stocks

Enter up to five stock symbols separated by a comma or space
(ex. BAC,WFC,JPM,LON:BARC).
Date Range: 

 LivaNovaGETINGE AB/ADRCONMEDNatus MedicalNatus Medical
SymbolNASDAQ:LIVNOTCMKTS:GNGBYNASDAQ:CNMDNASDAQ:NTUSN/A
Price Information
Current Price$74.91$16.77$97.82$33.34N/A
52 Week RangeBuyN/ABuyN/ABuy
Analyst Ratings
Consensus RecommendationBuyN/ABuyN/ABuy
Consensus Price Target$100.00N/A$106.25N/A$36.00
% Upside from Price Target33.50% upsideN/A8.62% upsideN/A∞ upside
Trade Information
Market Cap$3.61 billion$4.42 billion$2.76 billion$1.12 billion$1.09 billion
Beta0.541.820.510.730.57
Average Volume352,968888197,543141,094165,325
Sales & Book Value
Annual Revenue$1.11 billion$2.67 billion$859.63 million$530.89 million$530.89 million
Price / Sales3.271.713.222.140.00
Cashflow$4.94 per share$1.48 per share$4.44 per share$2.89 per shareN/A
Price / Cash15.1511.3522.0211.539.39
Book Value$30.89 per share$8.31 per share$23.54 per share$11.80 per share$11.80 per share
Price / Book2.422.024.162.830.00
Profitability
Net Income$-189,400,000.00$-111,300,000.00$40.85 million$-22,930,000.00$-22,930,000.00
EPS$3.17N/A$2.18$1.42$1.42
Trailing P/E Ratio23.6321.9244.8723.4822.48
Forward P/E Ratio22.0332.8219.380.00
P/E Growth$2.92N/A$2.28N/AN/A
Net Margins-23.86%4.08%3.13%-7.38%-7.38%
Return on Equity (ROE)8.56%9.14%9.95%10.73%10.79%
Return on Assets (ROA)5.16%4.11%4.31%6.61%6.57%
Dividend
Annual PayoutN/A$0.07$0.80N/AN/A
Dividend YieldN/A0.42%0.82%N/AN/A
Three-Year Dividend GrowthN/AN/AN/AN/AN/A
Payout RatioN/AN/A36.70%N/AN/A
Years of Consecutive Dividend GrowthN/AN/AN/AN/AN/A
Debt
Debt-to-Equity Ratio0.15%0.05%1.14%0.15%0.18%
Current Ratio0.95%0.87%2.55%1.93%1.70%
Quick Ratio0.67%0.55%1.44%1.36%1.18%
Ownership Information
Institutional Ownership Percentage88.37%0.04%N/A90.78%91.56%
Insider Ownership Percentage0.41%N/A4.38%1.65%1.65%
Miscellaneous
Employees4,00012,0003,1001,7291,729
Shares Outstanding48.39 million272.37 million28.29 million34.07 million34.01 million
Next Earnings Date10/30/2019 (Confirmed)1/29/2020 (Estimated)10/30/2019 (Confirmed)10/24/2019 (Confirmed)10/23/2019 (Estimated)
OptionableOptionableNot OptionableOptionableOptionableOptionable
 LivaNovaGETINGE AB/ADRCONMEDNatus MedicalNatus Medical

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.

Yahoo Gemini Pixel